Emory University’s Ascendis Pharma A/S ASND Stock Holding History

Emory University’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-18,334	Closed	-$2.11M	–	22
2019 Q2	$2.11M	Sell	18,334 -14,143	-44%	-$1.69M	1.49%	26
2019 Q1	$3.82M	Sell	32,477 -6,740	-17%	-$590K	2.69%	3
2018 Q4	$2.46M	Buy	39,217 +731	+2%	+$45.9K	1.94%	9
2018 Q3	$2.73M	Sell	38,486 -2,042	-5%	-$141K	1.78%	17
2018 Q2	$2.7M	Sell	40,528 -6,405	-14%	-$421K	1.79%	16
2018 Q1	$3.07M	Sell	46,933 -3,880	-8%	-$218K	2.19%	5
2017 Q4	$2.04M	Sell	50,813 -9,063	-15%	-$330K	1.75%	12
2017 Q3	$2.17M	Buy	59,876 +421	+0.7%	+$12.1K	1.72%	7
2017 Q2	$1.65M	Sell	59,455 -23,956	-29%	-$633K	1.46%	22
2017 Q1	$2.34M	Sell	83,411 -21,382	-20%	-$540K	2.2%	8
2016 Q4	$2.12M	Buy	+104,793	New	+$2.09M	2.09%	8

Other funds holding ASND

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Emory University's ASND Position: Q3 2019 in Review

Emory University sold out of Ascendis Pharma A/S (ASND) in Q3 2019, closing a stake of 18,334 shares — an estimated $2.11M sold.

Emory University first reported a position in ASND in Q4 2016 and held it in 11 quarters. The position peaked at $3.82M in Q1 2019. 129 funds tracked by Wall St. Rank hold ASND as of Q3 2019.

Emory University reported no remaining Ascendis Pharma A/S position as of Q3 2019 after selling out during the quarter.
Emory University sold 18,334 Ascendis Pharma A/S shares in Q3 2019, an estimated $2.11M.
Emory University first reported a position in Ascendis Pharma A/S in Q4 2016 and held it in 11 quarters.
Emory University's Ascendis Pharma A/S position peaked at $3.82M in Q1 2019.
129 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2019.

Based on Emory University's 13F filing for Q3 2019, filed 14 Nov 2019.